The a2 Milk Company (ATM) has received FDA clearance to sell Stage 1 and 2 a2 Platinum Infant Formula (IF) as part of the FDA's enforcement discretion to fill its shortage; Assuming ongoing approval, we estimate a base case valuation benefit of ~+NZ15–20cps